SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-11-000969
Filing Date
2011-02-22
Accepted
2011-02-22 17:24:14
Documents
6
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1210_dongsheng.htm 10-Q 538240
2 PRODUCT TRANSFER AND COOPERATION AGREEMENT f10q1210ex10i_dongsheng.htm EX-10.1 36405
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER f10q1210ex31i_dongsheng.htm EX-31.1 18999
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER f10q1210ex31ii_dongsheng.htm EX-31.2 19093
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER f10q1210ex32i_dongsheng.htm EX-32.1 8485
6 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER f10q1210ex32ii_dongsheng.htm EX-32.2 8451
  Complete submission text file 0001213900-11-000969.txt   631496
Mailing Address ROOM 10, 9TH FLOOR, BUILDING NO. 5 9 GAOSHENGQIAO ROAD, DAYI LOUVER PLAZA CHENGDU, SICHUAN PROVINCE F4 610041
Business Address ROOM 10, 9TH FLOOR, BUILDING NO. 5 9 GAOSHENGQIAO ROAD, DAYI LOUVER PLAZA CHENGDU, SICHUAN PROVINCE F4 610041 86-028-8506-8768
Dongsheng Pharmaceutical International Co., Ltd. (Filer) CIK: 0001444855 (see all company filings)

IRS No.: 262603989 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-154787 | Film No.: 11629546
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries